Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives

por Karachaliou, Niki, Fernandez Bruno, Manuel, Bracht, Jillian Wilhelmina Paulina, Rosell, Rafael
Publicado 2019

EGFR first- and second-generation TKIs—there is still place for them in EGFR-mutant NSCLC patients

por Karachaliou, Niki, Fernandez-Bruno, Manuel, Bracht, Jillian Wilhelmina Paulina, Rosell, Rafael
Publicado 2019

Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)

por Karachaliou, Niki, Cardona, Andres Felipe, Bracht, Jillian Wilhelmina Paulina, Aldeguer, Erika, Drozdowskyj, Ana, Fernandez-Bruno, Manuel, Chaib, Imane, Berenguer, Jordi, Santarpia, Mariacarmela, Ito, Masaoki, Codony-Servat, Jordi, Rosell, Rafael
Publicado 2018

BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale

por Bracht, Jillian Wilhelmina Paulina, Karachaliou, Niki, Bivona, Trever, Lanman, Richard B., Faull, Iris, Nagy, Rebecca J., Drozdowskyj, Ana, Berenguer, Jordi, Fernandez-Bruno, Manuel, Molina-Vila, Miguel Angel, Rosell, Rafael
Publicado 2019